MEG3 and rheumatoid arthritis: Compared with healthy control, the level of MEG3 in FLSs of RA patients was significantly down-regulated, and MEG3 was also significantly down-regulated in lipopolysaccharide (LPS)-treated chondrocytes (Wang et al., 2019a).